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In this issue of Critical Care, Lesur and colleagues [1] 
report the diﬀ  erential proﬁ  le of stress response in septic 
and non-septic patients. Adrenocorticotropic hormone 
(ACTH) and ACTH/cortisol ratio were lower whereas 
baseline cortisol, procalcitonin (PCT), and stromal cell-
derived factor-1-alpha (SDF-1α) were higher in septic 
patients than in non-septic patients. Furthermore, a 
probability score incorporating ACTH, cortisol, and PCT 
by multivariate logistic regression analysis predicted 
sepsis better than sepsis score or PCT did [1].
Th   e response of hypothalamic-pituitary-adrenal (HPA) 
axis to the sustained stress of severe illness has been the 
focus of many studies in recent years. In healthy subjects, 
cortisol secretion by adrenal cortex is regulated by ACTH 
secretion by the pituitary, which in turn is regulated 
primarily by hypothalamic secretion of corticotropin-
releasing hormone (CRH), whereas cortisol inhibits both 
ACTH and CRH production through a negative feedback 
[2-4].
However, HPA stress response during sepsis is much 
more complex and is poorly deﬁ   ned. Plasma cortisol 
levels may be low, normal, or high in sepsis [2,5] but 
nonetheless inadequate to control the inﬂ  ammatory res-
ponse and meet the elevated metabolic demand [5]. Th  is 
eﬀ  ect is termed relative adrenal insuﬃ   ciency (RAI), also 
known as critical illness-related corticosteroid insuﬃ   -
ciency (CIRCI) [2,3,6].
Other factors are involved in the HPA stress response 
during sepsis [6,7]. In rodent models, arginine vaso-
pressin (AVP) was shown to increase endogenous adrenal 
ACTH secretion [7]. Apelin, a neuropeptide originating 
from paraventricular and supraopitc nuclei, acts on HPA 
axis regulation by releasing CRH and ACTH and by 
reducing AVP [7]. Copeptin, a 39-amino acid glyco-
peptide, makes up the pre-pro-vasopressin molecule 
together with neurophysin II and AVP and serves as a 
surrogate marker to assess AVP plasma concentrations in 
septic shock [8]. In normal rats, the chemokine SDF-1α 
and its receptor colocalize with AVP in magnocellular 
neurosecreatory neurons, resulting in an inhibition of 
AVP-induced release [9].
Real life is even more complex. Th   e HPA may display a 
biphasic pattern during the course of a critical illness 
[4,10]. Th  e dissociation of ACTH and cortisol levels in 
late phase (lasting many days to weeks), which is diﬀ  erent 
from that of the acute phase (hours to a few days) of an 
illness, indicates that alternative pathways not mediated 
by ACTH are involved. Moreover, androgens produced 
by zona reticularis are aﬀ   ected in sepsis or CIRCI. 
Limited clinical studies prove that the dehydro-
epiandrosterone (DHEA) level is very low in septic shock, 
whereas its sulphate and the cortisol/DHEA ratio might 
be prognostic markers and signs of exhausted adrenal 
reserve in critical illness [11]. Tissue resistance to cortico-
steroid action may also play an important role in sepsis 
[6] and can be caused by either defects in the 
corticosteroid receptor or postreceptor alterations and 
may not be deﬁ  ned accurately based on plasma cortisol 
levels [3,4].
Abstract
The hypothalamic-pituitary-adrenal (HPA) axis response 
in sepsis remains to be elucidated. Apart from 
corticotropin-releasing hormone, adrenocorticotropic 
hormone, and cortisol, many other neuroendocrine 
factors participate in the regulation of HPA stress 
response. The HPA response to acute and chronic 
illness exerts a biphasic profi  le. Tissue corticosteroid 
resistance may also play an important role. All of 
these add to the complexity of the concept of ‘relative 
adrenal insuffi   ciency’ and may account for the diffi   culty 
of clinical diagnosis and for the confl  icting results of 
corticosteroid replacement therapy in severe sepsis/
septic shock. The study by Lesur and colleagues 
expands our understanding of the mechanism, and 
further study of HPA stress response is warranted.
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criteria, clinical studies show that patients with RAI are 
at a signiﬁ  cantly higher risk of hospital mortality [12] and 
this has been the driver for corticosteroid replacement 
therapy in severe sepsis/septic shock [2-4]. However, 
clinical trials with stress-dose corticosteroid show con-
ﬂ  ict  ing results [13,14]. Th   is is not surprising upon review 
of the aforementioned complexity and unknowns of HPA 
stress response. Furthermore, it must be acknowledged 
that the decision to treat with stress-dose corticosteroids 
is based on clinical criteria rather than on the in-
conclusive results of adrenal function tests.
Th   e limitations of the study by Lesur and colleagues [1] 
should be considered. Th  e dissociation of ACTH and 
cortisol levels observed in the study is more compatible 
with neuroendocrine characteristics of prolonged critical 
illness [4], although the authors claimed to include 
patients within the ﬁ  rst 24 hours of admission [1]. Th  e 
clinical signiﬁ  cance of the predictive model is hindered 
by the unavailability of ACTH or cortisol measurements 
at the bedside and by the fact that the predictive value of 
sepsis score or PCT has not been consistently validated 
in clinical trials [15].
Despite all of these limitations, the study by Lesur and 
colleagues undoubtedly expands our understanding of 
the complex neuroendocrine network regulating HPA 
stress response in human sepsis. We believe that further 
investi  gation into the mechanism is warranted before we 
plan a success  ful strategy for corticosteroid replacement 
in sepsis.
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